CN Patent

CN1187121A — 碱化钾盐控释制剂

Assigned to Church and Dwight Co Inc · Expires 1998-07-08 · 28y expired

What this patent protects

由碱化钾盐作为活性成分混合成的多颗粒控释制剂,其中优选碳酸氢钾,该制剂适用于制成口服给药的药物制剂。此种制剂用于作为补钾剂,并治疗骨退化症或心血管疾病,例如骨质疏松症和高血压。

USPTO Abstract

由碱化钾盐作为活性成分混合成的多颗粒控释制剂,其中优选碳酸氢钾,该制剂适用于制成口服给药的药物制剂。此种制剂用于作为补钾剂,并治疗骨退化症或心血管疾病,例如骨质疏松症和高血压。

Drugs covered by this patent

carvedilol-phosphate (CARVEDILOL PHOSPHATE)

Patent Metadata

Patent number: CN1187121A
Jurisdiction: CN
Classification: —
Expires: 1998-07-08
Drug substance claim: No
Drug product claim: No
Assignee: Church and Dwight Co Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.